Pharos Indonesia PT

What Pharos Indonesia PT does

PT Pharos Indonesia is a privately held Indonesian pharmaceutical manufacturer founded in 1971 by Eddie Lembong and headquartered in South Jakarta. The company describes itself as one of the largest pharmaceutical companies in Indonesia and operates through the Pharos Group, which comprises four wholly-owned subsidiaries spanning ethical drugs, OTC medicines, supplements, herbal products, cosmetics, and medical devices. Its branded portfolio includes hundreds of SKUs across categories such as fever/pain relief (Proris, Praxion, Exedra Rema), digestive health (Polysilane, Microlax, Colidan), allergies (Ozen), supplements (Omepros, Enaplex-C, Fishqua, Igastrum), skincare (Nourish Skin, Nourish Beauty Care Acne Plast), and medical devices (Keloplast, Hycocare Foot Plast).

Manufacturing is conducted under CPOB (Cara Pembuatan Obat yang Baik) certification with products registered through BPOM. Proprietary formulation technologies include micronized paracetamol for faster absorption, PureWay-C fat-soluble Vitamin C, and Korean-technology hydrocolloid acne patches. Multiple brands have received Top Brand Awards, including Microlax, Proris, Thermolyte Plus, and Nourish Skin.

The business model is B2B2C: the company manufactures branded pharmaceutical and consumer health products and distributes them through traditional apotek networks across Indonesia, modern e-commerce marketplaces (Tokopedia, Shopee), and direct healthcare-facility relationships. Revenue is generated through one-time product sales at retail; pricing is not publicly disclosed. GTM combines a field sales force (sales-led) with channel-partner distribution, supported by content marketing, social media, professional pharmacist engagement (e.g., the INSPIRE Roadshow with IAI), and community programs targeting parents, youth, and the elderly. End consumers are individual Indonesian households purchasing OTC medicines, supplements, and personal-care products; institutional customers (pharmacies, hospitals) act as distribution partners rather than revenue anchors.

Name

Pharos Indonesia PT

Legal name

PT. Pharos Indonesia

Website

https://pharos.co.id

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

11–50 employees

Short description

PT Pharos Indonesia is a privately held Indonesian pharmaceutical manufacturer founded in 1971, producing and distributing hundreds of OTC medicines, supplements, herbal products, cosmetics, and medical devices under proprietary brands through pharmacy and e-commerce channels to Indonesian consumers.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Health and Personal Care Retailers (4561)

SIC

Pharmaceutical Preparations (2834), Perfumes, Cosmetics & Other Toilet Preparations (2844), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Vitamins & Minerals (Single Nutrients) (CRADAGAB)

akta.pro secondary industries

Hair Care (Shampoo, Conditioner, Styling, Treatments) (CRADANAE), Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE)

Keywords

• Pharmaceutical manufacturing
• Over-the-counter medicines
• Dietary supplements
• Skincare products
• Medical devices

Headquarters

HQ city

Jakarta, Jakarta

HQ country

Indonesia

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmaceutical Manufacturing and Sales: PT Pharos Indonesia manufactures and markets pharmaceutical products including ethical prescription drugs, OTC medications, supplements, herbal products, and medical devices through pharmacy and retail channels.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

PT Pharos Indonesia manufactures and markets a broad portfolio of branded pharmaceutical and consumer health products for the Indonesian market. Its core offerings include ethical (prescription) drugs, OTC medications, dietary supplements, herbal products, skincare, and medical devices, distributed through pharmacy networks, healthcare facilities, and e-commerce platforms across Indonesia.

Product overview

PT Pharos Indonesia is one of Indonesia's largest pharmaceutical companies, founded in 1971, producing and marketing innovative pharmaceutical products. The company operates a portfolio-based model with multiple product lines across several categories: prescription drugs (Ethical), over-the-counter (OTC) medicines, supplements, herbal products, skincare, medical devices, and health accessories. Key brands include Microlax (laxatives), Proris (children's fever medicine), Polysilane (antacids), Omepros (omega supplements), Nourish Beauty Care (skincare including Acne Plast patches), Colidan (stomach health), and various other pharmaceutical and supplement products. The company also includes subsidiaries: PT. Primaxcel Inovasi (cosmetics and beauty care), PT. Prima Medika Laboratories, and PT. Perusahaan Dagang dan Industri Faratu (ethical and OTC pharmaceuticals).

Differentiator

Problem solved

Functional benefit

Brands

• Proris: Brand of children's fever-reducing medication and pain reliever products, including Proris Suspension and Proris Forte.
• Microlax
• Polysilane
• Nourish Skin
• Omepros
• Praxion
• Albusmin
• Ozen
• Enaplex-C
• Colidan
• Fishqua
• Igastrum
• Illuminare
• HospiNet
• Panakea

Quantifiable outcome

• Products registered with BPOM and certified compliant with Good Manufacturing Practices
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered minor and core.

• Senior Club Indonesia (SCI)minorStrategic or Co-development Partner · 1 March 2026Pharos Indonesia partnered with Senior Club Indonesia to support elderly health activities commemorating National Music Day on March 11, 2026. The partnership focuses on promoting health awareness among elderly community members.
• Ikatan Apoteker Indonesia (IAI)coreStrategic or Co-development Partner · 1 December 2024PT Pharos Indonesia together with IAI organized the INSPIRE (Indonesian Smart Pharmacy and Entrepreneurship Roadshow) seminar for pharmacists on December 21-22, 2024 in Bogor and Bekasi. The program aims to enhance pharmacist competency and knowledge in pharmaceutical science.
• Badan Pengawas Obat dan Makanan (BPOM) RIcoreOthersPharos Indonesia actively participates in BPOM initiatives including Safe Sound Fest 2026, Expo BPOM 2026 (25th BPOM Anniversary), and supports BPOM's Net Zero Carbon Programme through mangrove ecosystem conservation. Company products comply with BPOM standards.
• Universitas BPD SemarangminorStrategic or Co-development PartnerHosted 'Glow Up Tanpa Tekanan' talkshow on healthy lifestyle for young generation on February 11, 2026 at Universitas BPD Semarang. Event was attended by hundreds of students from SMA/SMK/MA schools.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Kimia Farma: State-owned Indonesian pharmaceutical company (IDX: KAEF) operating manufacturing and pharmacy retail. Overlaps with Pharos in pharmaceutical manufacturing and competes through its apotek retail network.
• Indofarma: State-owned Indonesian pharmaceutical manufacturer (IDX: INAF) producing generic and OTC medicines. Competes with Pharos in similar categories though with different scale and portfolio focus.
• Darya-Varia Laboratoria: Indonesian pharmaceutical manufacturer (IDX: DVLA) producing prescription, OTC, and consumer health products including Natur-E supplements. Closely comparable in scale and therapeutic category coverage.
• Sanbe Farma: Major Indonesian pharmaceutical manufacturer producing ethical, OTC, and supplement products. Competes with Pharos in similar therapeutic categories with comparable multi-subsidiary structure.
• Dexa Medica: Indonesian pharmaceutical company with strong prescription drug and supplement portfolio including brands like Stimuno. Direct competitor to Pharos in ethical and consumer health segments.
• Tempo Scan Pacific: Indonesian pharmaceutical manufacturer and distributor (IDX: TSPC) with comparable portfolio spanning prescription drugs, OTC, and consumer health products. Closest direct peer in scale and product mix to Pharos.
• Kalbe Farma: Indonesia's largest pharmaceutical company, publicly listed on IDX (KLBF). Competes directly with Pharos across ethical, OTC, and supplement categories, but at significantly larger scale with broader distribution and consumer health brands.

Broad incumbents

• Pfizer Indonesia: Multinational pharmaceutical company with Indonesian operations. Competes with Pharos in ethical/prescription categories and increasingly in OTC, but with global R&D pipeline and substantially larger scale.
• Reckitt Benckiser Indonesia: Multinational consumer health company with Indonesian OTC presence (e.g., digestive health, analgesics). Overlaps with Pharos in OTC categories such as Polysilane and Exedra but operates as part of a global portfolio across health, hygiene, and nutrition.
• Bayer Indonesia: Multinational pharmaceutical and consumer health company with Indonesian operations. Overlaps with Pharos in OTC categories (analgesics, digestive health) but operates as part of a broader global portfolio rather than Indonesia-specialist focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/pharos-indonesia-pt

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharos Indonesia PT